BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8626530)

  • 1. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
    Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
    J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.
    Pronk GJ; de Vries-Smits AM; Buday L; Downward J; Maassen JA; Medema RH; Bos JL
    Mol Cell Biol; 1994 Mar; 14(3):1575-81. PubMed ID: 8114695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
    J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The signaling pathway coupling epidermal growth factor receptors to activation of p21ras.
    Sasaoka T; Langlois WJ; Leitner JW; Draznin B; Olefsky JM
    J Biol Chem; 1994 Dec; 269(51):32621-5. PubMed ID: 7798267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.
    Waters SB; Chen D; Kao AW; Okada S; Holt KH; Pessin JE
    J Biol Chem; 1996 Jul; 271(30):18224-30. PubMed ID: 8663461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts.
    Haugh JM; Huang AC; Wiley HS; Wells A; Lauffenburger DA
    J Biol Chem; 1999 Nov; 274(48):34350-60. PubMed ID: 10567412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
    Smit L; van der Horst G; Borst J
    J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
    Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
    J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
    J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex.
    Holt KH; Waters SB; Okada S; Yamauchi K; Decker SJ; Saltiel AR; Motto DG; Koretzky GA; Pessin JE
    J Biol Chem; 1996 Apr; 271(14):8300-6. PubMed ID: 8626525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbachol activates ERK2 in isolated gastric parietal cells via multiple signaling pathways.
    Takeuchi Y; Pausawasdi N; Todisco A
    Am J Physiol; 1999 Jun; 276(6):G1484-92. PubMed ID: 10362652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
    Curto M; Frankel P; Carrero A; Foster DA
    Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.
    Harmer SL; DeFranco AL
    Mol Cell Biol; 1997 Jul; 17(7):4087-95. PubMed ID: 9199344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway.
    Prigent SA; Nagane M; Lin H; Huvar I; Boss GR; Feramisco JR; Cavenee WK; Huang HS
    J Biol Chem; 1996 Oct; 271(41):25639-45. PubMed ID: 8810340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.